This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

III. Adjustment of Nonrelapsed Patients

Gerard E. Hogarty, MSW; Solomon C. Goldberg, PhD; Nina R. Schooler, PhD; the Collaborative Study Group

Arch Gen Psychiatry. 1974;31(5):609-618.

Abstract
We examined the effects of chlorpromazine and major role therapy (MRT) on the quality of community adjustment of schizophrenic patients during a two-year period following hospital discharge.

Among patients in the community, those treated with combined drug and sociotherapy adjust better than those taking the drug alone; to a greater extent, those receiving placebo alone adjust better than those receiving placebo and sociotherapy. However, only 20% of those in the placebo group have not relapsed after two years while the comparable percentage for the drug group is 52%.

Effects found on assessments made by psychiatrists, social workers, family ratings, and self-reports replicate at three clinics.

Maximum restorative benefits require both maintenance phenothiazine and psychologic treatment continued for beyond a single year following hospital discharge.

Author Affiliations
From the Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine (Mr. Hogarty); the Psychopharmacology Research Branch, National Institute of Mental Health, Rockville, Md (Drs. Goldberg and Schooler); and the Friends' Medical Science Research Center, Inc, Baltimore (the Collaborative Study Group).

Footnotes
Accepted for publication July 18, 1974.

Reprint requests to 3811 O'Hara St, Pittsburgh, PA 15261 (Mr. Hogarty).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cognitive Enhancement Therapy for Early-Course Schizophrenia: Effects of a Two-Year Randomized Controlled Trial
Eack et al.
Psychiatr. Serv. 2009;60:1468-1476.
ABSTRACT | FULL TEXT  

Gerard E. Hogarty (1935 2006): Combining Science and Humanism to Improve the Care of Persons With Schizophrenia
Eack et al.
Schizophr Bull 2007;33:1056-1062.
ABSTRACT | FULL TEXT  

Durability and Mechanism of Effects of Cognitive Enhancement Therapy
Hogarty et al.
Psychiatr. Serv. 2006;57:1751-1757.
ABSTRACT | FULL TEXT  

Cognitive Enhancement Therapy for Schizophrenia: Effects of a 2-Year Randomized Trial on Cognition and Behavior
Hogarty et al.
Arch Gen Psychiatry 2004;61:866-876.
ABSTRACT | FULL TEXT  

Three-Year Trials of Personal Therapy Among Schizophrenic Patients Living With or Independent of Family, I: Description of Study and Effects on Relapse Rates
Hogarty et al.
Focus 2004;2:146-157.
ABSTRACT | FULL TEXT  

Integration of Care: Integrated Treatment of Schizophrenia
Lenroot et al.
Psychiatr. Serv. 2003;54:1499-1507.
ABSTRACT | FULL TEXT  

Three-Year Trials of Personal Therapy Among Schizophrenic Patients Living With or Independent of Family, I: Description of Study and Effects on Relapse Rates
Hogarty et al.
Am. J. Psychiatry 1997;154:1504-1513.
ABSTRACT | FULL TEXT  

Three-Year Trials of Personal Therapy Among Schizophrenic Patients Living With or Independent of Family, II: Effects on Adjustment of Patients
Hogarty et al.
Am. J. Psychiatry 1997;154:1514-1524.
ABSTRACT | FULL TEXT  

Family Psychoeducation, Social Skills Training, and Maintenance Chemotherapy in the Aftercare Treatment of Schizophrenia: II. Two-Year Effects of a Controlled Study on Relapse and Adjustment
Hogarty et al.
Arch Gen Psychiatry 1991;48:340-347.
ABSTRACT  

Family Interventions for Schizophrenia
Tarrier and Barrowclough
Behav Modif 1990;14:408-440.
ABSTRACT  

Family Psychoeducation, Social Skills Training, and Maintenance Chemotherapy in the Aftercare Treatment of Schizophrenia: I. One-Year Effects of a Controlled Study on Relapse and Expressed Emotion
Hogarty et al.
Arch Gen Psychiatry 1986;43:633-642.
ABSTRACT  

The Chestnut Lodge Follow-up Study: I. Follow-up Methodology and Study Sample
McGlashan
Arch Gen Psychiatry 1984;41:573-585.
ABSTRACT  

Sex Difference in Age at Onset of Schizophrenia
Loranger
Arch Gen Psychiatry 1984;41:157-161.
ABSTRACT  

Low-Dose Neuroleptic Treatment of Outpatient Schizophrenics: I. Preliminary Results for Relapse Rates
Kane et al.
Arch Gen Psychiatry 1983;40:893-896.
ABSTRACT  

Effects of Thioridazine on the Intellectual Performance of Mentally Retarded Drug Responders and Nonresponders
Breuning et al.
Arch Gen Psychiatry 1983;40:309-313.
ABSTRACT  

Evaluating the Outcomes of Human Service Programs: A Reassessment
Neigher and Schulberg
Eval Rev 1982;6:731-752.
ABSTRACT  

Personality Determinants of Leadership and Participation in a Sociotherapy Program
Smith and Fromm
Human Relations 1982;35:433-448.
ABSTRACT  

Prevention of Relapse in Schizophrenia: An Evaluation of Fluphenazine Decanoate
Schooler et al.
Arch Gen Psychiatry 1980;37:16-24.
ABSTRACT  

Does Follow-Up Loss Reflect Poor Outcome?
Ellsworth
Eval Health Prof 1979;2:419-437.
ABSTRACT  

Fluphenazine and Social Therapy in the Aftercare of Schizophrenic Patients: Relapse Analyses of a Two-Year Controlled Study of Fluphenazine Decanoate and Fluphenazine Hydrochloride
Hogarty et al.
Arch Gen Psychiatry 1979;36:1283-1294.
ABSTRACT  

Day Treatment and Psychotropic Drugs in the Aftercare of Schizophrenic Patients: A Veterans Administration Cooperative Study
Linn et al.
Arch Gen Psychiatry 1979;36:1055-1066.
ABSTRACT  

Psychiatry
Freedman
JAMA 1979;241:1373-1375.
ABSTRACT  

Controlled Evaluation of a Hospital-Originated Community Transitional System
Kuldau and Dirks
Arch Gen Psychiatry 1977;34:1331-1340.
ABSTRACT  

Temporal Effects of Drug and Placebo in Delaying Relapse in Schizophrenic Outpatients
Hogarty and Ulrich
Arch Gen Psychiatry 1977;34:297-301.
ABSTRACT  

Prediction of Outcome in Schizophrenia: III. Five-Yearn Outcome and Its Predictors
Strauss and Carpenter
Arch Gen Psychiatry 1977;34:159-163.
ABSTRACT